Providing to its clients high value and high quality pharmaceutical CMC product development and full testing services focused primarily on parenteral and topical drug products. These services include formulation development, analytical development, microbiological development and clinical manufacturing (Phase 1 & 2). Further, SL Pharma has established an excellent track record of successfully developing several INDs/NDAs (including 505-b) as well as generic drug products (ANDAs) leading to regulatory approvals and commercialization. In addition SL Pharma Labs has also served many clients and CMOs for the full analytical and microbiological quality control release and stability testing of marketed drug products, notably parenterals. Because of its highly experienced leadership and very competent technical staff, SL Pharma has established its reputation for delivering high quality and great efficiency with tight timelines at competitive costs. SL Pharma Labs mission is to support clients in meeting product development, analysis, regulatory approval and commercialization timelines and budgetary requirements.